Department of Economics and Business, National Centre for Register-based Research, School of Business and Social Sciences, Aarhus University, Fuglesangs Allé 4 Building K, 8210, Aarhus, Denmark,
Eur Child Adolesc Psychiatry. 2014 Sep;23(9):841-4. doi: 10.1007/s00787-013-0508-5. Epub 2013 Dec 29.
Assessing whether symptoms of attention-deficit hyperactivity disorder (ADHD) in children are age-inappropriate is essential. Hence, comparing children within one school grade is problematic and the risk of applying relative standards is inherent. Being young-for-grade increases the likelihood of receiving medication in countries with high prevalence of ADHD medication. We test the same hypothesis in a cohort of 418,396 children and find no difference between children who are young-for-grade and old-for-grade. The Danish system, with its restrictive approach to medication and clear diagnostic guidelines seems to have avoided a systematic bias of ADHD medication in young children reported in other countries.
评估儿童注意缺陷多动障碍 (ADHD) 症状是否与年龄不相符至关重要。因此,将同一学校年级的儿童进行比较存在问题,而且应用相对标准的风险是内在的。在 ADHD 药物治疗盛行的国家,年级较小的儿童更有可能接受药物治疗。我们在一个由 418396 名儿童组成的队列中检验了相同的假设,结果发现年龄较小和年龄较大的儿童之间没有差异。丹麦的医疗体系对药物治疗采取限制措施,并制定了明确的诊断指南,这似乎避免了其他国家报告的 ADHD 药物治疗在幼儿中出现的系统偏差。